Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcinite-D is an over-the-counter dietary supplement developed and marketed by Alico Pharmaceutical. It is a combination formulation containing calcium and vitamin D3 (cholecalciferol), designed to support bone health and address nutritional deficiencies. Calcium serves as a primary structural component of bone tissue and is vital for various physiological processes, including muscle contraction and nerve signaling. Vitamin D3 acts as a precursor to calcitriol, which binds to the vitamin D receptor (VDR) to promote the intestinal absorption of calcium. The product is typically used for the prevention and treatment of conditions such as osteoporosis, osteomalacia, and calcium or vitamin D deficiencies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium + cholecalciferol (Alico Pharmaceutical).